Sfoglia per Autore
REVERSAL and PROVE-IT: are clinically oriented trials really better than "pure" scientific studies?
2005 Cicero AF; Gaddi A.
Treatment of peripheral obstructive artery disease: a battle that could be winned also with drugs? [Trattamento dell'arteriopatia obliterante degli arti inferiori: Una battaglia che può essere vinta anche con i farmaci?]
2005 Gaddi AV; Cicero AF
Primary variation in serum HDL-cholesterol levels: an independent cardiovascular risk factor in healthy adults?
2005 Bove M, Cicero AFG; Lucicesare A, Aronis K, Georgounis I, Gaddi AV
Causes of statin interruption by hyperlipidaemic patients: the result of survey on 218 consecutive patients.
2005 Cicero AFG; Bove M; Lucicesare A; Laghi L; Linarello S; Bernardi R; Gaddi AV.
Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardio-vascular disease: response to Beishuizen et al.
2005 Cicero AF; Gaddi AV; Derosa G.
Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension.
2005 Derosa G; Cicero AF; Gaddi A; Mugellini A; Ciccarelli L; Fogari R.
Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates.
2005 Cicero AF; Derosa G; Miconi A; Laghi L; Nascetti S; Gaddi A.
Cost-effetiveness analysis of complementary care for hyperlipidameias
2005 Cicero AFG; Bove M; Lucicsare A; Laghi L; Gaddi AV.
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride.
2005 Derosa G.; Cicero A.; D’Angelo A.; Gaddi A.; Ragonesi P.D.; Piccinni M.N.; Salvadeo S.; Ciccarelli L.; Pricolo F.; Ghelfi M.; Ferrari I.; Montagna L.; Fogari R.
Sindromi Metaboliche: diagnosi, prognosi e terapia.
2005 Gaddi AV; Cicero AFG.
Le dislipidemie nel paziente diabetico.
2005 Cucinotta D; Gaddi AV; Russo GT; Cicero AFG.
Case Report: lipoproteina (A) is an indipendent risk factor for coronary artery disease: diagnosis and follow-up of a patient with high level of Lp(a) as only cardiovascular risk factor
2005 Bernardi R.; D'Addato S.; Dormi A.; Brillante R.; Laghi L.; Linarello S.; Grandi E.; Gaddi A.
Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial.
2005 Derosa G; Gaddi AV; Ciccarelli L; Fogari E; Ghelfi M; Ferrari I; Cicero AF.
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
2005 Derosa G; Gaddi AV; Piccinni MN; Ciccarelli L; Salvadeo S; Peros E; Ghelfi M; Ferrari I; Cicero AF.
Relative role of major risk factors for Type 2 Diabetes development in the historical cohort of the Brisighella Heart Study: an 8-years follow-up.
2005 CICERO AFG; DORMI A; NASCETTI S; Panourgia MP; Grandi E; DADDATO S; GADDI A.
Iperlipoproteinemia familiare combinata: complicanze cardiovascolari e cerebrovascolari
2005 Laghi L.; Cicero A.F.G.; D'Addato S.; Dormi A.; Fiorito A.; Gaddi A.
Linkage disequilibrium patterns and tagSNP transferability among European populations.
2005 MUELLER JC; LOHMUSSAAR E; MAGI R; REMM M; BETTECKEN T; LICHTNER P; BISKUP S; ILLIG T; PFEUFER A; LUEDEMANN J; SCHREIBER S; PRAMSTALLER P; PICHLER I; ROMEO G; GADDI A.; TESTA A; WICHMANN HE; METSPALU A; MEITINGER T.
Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
2005 Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R.
Effect of Sulodexide on Albuminuria, NAG Excretion and Glomerular Filtration Response to Dopamine in Diabetic Patients.
2006 Sulikowska B.; Olejniczak H.; Muszynska M.; Odrowaz-Sypniewska G.; Gaddi A.V.; Savini C.; Cicero A.F.G.; Laghi L.; Manitius J.
Metabolic Syndrome prevalence in Italy.
2006 Cicero A.F.G.; Nascetti S.; Noera G.; Gaddi A.V.; for the Massalombarda Project Team
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile